Glicia-30 MR (Gliclazide Modified Release) is designed for effective and convenient blood sugar control.
The Modified Release (MR) technology allows the 30 mg of Gliclazide to be absorbed gradually into the bloodstream over a 24-hour period. Gliclazide works by stimulating the beta cells in the pancreas to release insulin more effectively, particularly in response to meals. This helps in lowering both fasting and post-meal blood glucose levels.
Because of its unique release profile, Glicia-30 MR carries a lower risk of hypoglycemia (sudden sugar drops) compared to older sulfonylureas. Consistent use, along with proper diet and exercise, helps prevent long-term diabetic complications such as kidney damage, vision loss, and nerve problems.
Key Benefits
-
24-Hour Control: Steady release provides consistent sugar management with a single dose.
-
Meal-Time Response: Effectively manages glucose spikes after eating.
-
Improved Safety: Lower risk of hypoglycemia due to the controlled-release mechanism.
-
Vascular Health: Helps protect small blood vessels from diabetic damage.
-
Trusted Quality: High pharmaceutical standards from DH.
Directions for Use
-
Take this medicine in the dose and duration as advised by your doctor.
-
Usually taken once daily at breakfast time.
-
Swallow the tablet whole with water.
-
Do not crush, chew, or break it, as this will destroy the Modified Release (MR) property.
Safety & Precautions
-
Rx Only: A valid medical prescription is mandatory.
-
Hypoglycemia Alert: Always carry a sugar source (like juice or glucose tabs) in case of low blood sugar symptoms.
-
Inform your doctor if you have severe kidney or liver disease.
-
Do not skip meals while taking this medication.
-
Consult your physician regarding alcohol consumption as it can interfere with blood sugar stability.
Storage
-
Store in a cool, dry place.
-
Protect from direct sunlight and moisture.
-
Keep out of reach of children.
